Stockreport

23andMe Announces the Appointment of Joseph R. Arron, M.D., Ph.D. as Chief Scientific Officer

23andMe Holding Co.  (ME) 
PDF SUNNYVALE, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and therapeutics company, today announce [Read more]